Herein, we aimed to determine the serum levels of LAMP-2 in patients with PBC and to evaluate whether serum levels of LAMP-2 could serve as a predictor of poor outcome after UDCA treatment in patients with PBC. This evidence concerns the gene LAMP2 and primary biliary cholangitis.